Salt Lake City, Utah, Sept. 09, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company") a leading innovator in ceramic manufacturing, today announced that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for patent application no. 17/634,141 entitled "Methods of Surface Functionalization of Zirconia-Toughed Alumina with Silicon Nitride Ceramic." This Notice of Allowance is expected to result in the issuance of a U.S. patent once administrative processes are completed. This patent allowance underscores the Company's commitment to advancing the development of advanced ceramic for biomaterial applications, p
Salt Lake City, Utah, Sept. 05, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company") a leading innovator in ceramic manufacturing, today announced the completion of the first series of strategic initiatives aimed at strengthening the Company's financial position and enhancing its long-term growth prospects. As part of this comprehensive effort to optimize the company's financials, SINTX initiated strategic measures including: raised additional capital through the sale of common stock under the Company's current At-The-Market (ATM) offering.reduced expenses in an amount that we believe will result in an over 50% reduction in cash used in operating
Salt Lake City, Utah., Aug. 06, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company") today announced that its Board of Directors has appointed Eric K. Olson to succeed B. Sonny Bal, MD as the Company's Chief Executive Officer and President. Mr. Olson's appointment follows the Company's recent announcement that Dr. Bal was retiring from his position as Chief Executive Officer and President effective upon the appointment of a new chief executive officer and president by the Board of Directors. Dr. Bal will continue to serve as Chairman of the Board on the Company's Board of Directors. For over 30 years, Mr. Olson has been a serial founder and entrepren
10-Q - Sintx Technologies, Inc. (0001269026) (Filer)
8-K - Sintx Technologies, Inc. (0001269026) (Filer)
8-K - Sintx Technologies, Inc. (0001269026) (Filer)
The Acquisition Broadens Opportunities for SINTX in Aerospace, Defense, and Biomedical Markets SALT LAKE CITY, July 06, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, announced the acquisition of Technology Assessment and Transfer, Inc. (TA&T; https://www.techassess.com/), significantly increasing SINTX's capabilities in the aerospace, defense, and biomedical markets. "We are excited to acquire TA&T and take another step towards diversifying and strengthening SINTX," said Dr. Sonny Bal, President and CEO of SINTX. "TA&T will expand our use of advanced manufacturing techno
SALT LAKE CITY, March 25, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, announced today the filing of its Annual Report on Form 10-K for the year ended December 31, 2021 with the U.S. Securities and Exchange Commission. In 2021, SINTX made significant investments into the expansion of its three priority business segments - biomedical, industrial/armor, and antipathogenic - through the purchase of new technology, equipment, and personnel. The Company is narrowly focused on opportunities closest to revenue such as armor materials and plates, the development of new biomedi
SALT LAKE CITY, June 30, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer of silicon nitride ceramic for medical and non-medical applications, announced today it has moved into the next phase of its relationship with O2TODAY and sold the first shipment of FleX SN-AP antipathogenic silicon nitride powder to O2TODAY for integration into a proprietary line of masks and filters. "O2TODAY announced on its website today that it is taking limited pre-orders for masks and mask filters integrated with SINTX's antipathogenic powder," said Dr. Sonny Bal, President and CEO at SINTX Technologies. "We share th
SC 13G - Sintx Technologies, Inc. (0001269026) (Subject)
SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)
SC 13G - Sintx Technologies, Inc. (0001269026) (Subject)
4 - Sintx Technologies, Inc. (0001269026) (Issuer)